These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1525611)

  • 1. Tumor necrosis factor-alpha associated with chronic graft-versus-host disease in bone marrow transplantation recipients.
    Fujii Y; Kaku K; Kaneko T
    Bone Marrow Transplant; 1992 Aug; 10(2):194-5. PubMed ID: 1525611
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantation.
    Robinet E; Pico JL; Ibrahim A; Ostronoff M; Zambon E; Zohar M; Truneh A; Gay F; Hayat M; Chouaib S
    Bone Marrow Transplant; 1991; 7 Suppl 2():148. PubMed ID: 1652325
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
    Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
    Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
    Holler E; Kolb HJ; Hintermeier-Knabe R; Mittermüller J; Thierfelder S; Kaul M; Wilmanns W
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1234-6. PubMed ID: 8442099
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphokines and the acute-phase response in clinical bone marrow transplantation.
    Cohen J; Bayston K
    Eur Cytokine Netw; 1990; 1(4):251-5. PubMed ID: 1716489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
    Alessandrino EP; Bernasconi P; Colombo A; Boni M; Bonfichi M; Caldera D; Bernasconi C
    Bone Marrow Transplant; 1991; 7 Suppl 2():51. PubMed ID: 1878716
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of leukemia with partially matched related bone marrow transplantation.
    Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS
    Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in graft-versus-host disease.
    Andolina M; Rabusin M; Maximova N; Di Leo G
    Bone Marrow Transplant; 2000 Oct; 26(8):929. PubMed ID: 11081399
    [No Abstract]   [Full Text] [Related]  

  • 13. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
    Remberger M; Ringden O; Markling L
    Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cytokine levels in patients undergoing bone marrow transplantation.
    Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
    Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Kai S; Shinohara Y; Ifuku H; Ohe Y; Misawa M; Noguchi K; Kohsaki M; Kanamaru A; Hara H; Nagai K
    Rinsho Ketsueki; 1985 Jan; 26(1):20-7. PubMed ID: 3889401
    [No Abstract]   [Full Text] [Related]  

  • 17. CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease.
    Matthes-Martin S; Aberle SW; Peters C; Holter W; Popow-Kraupp T; Pötschger U; Fritsch G; Ladenstein R; Rosenmayer A; Dieckmann K; Gadner H
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S53-6. PubMed ID: 9630327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid analysis of tumor necrosis factor-alpha mRNA expression during venoocclusive disease of the liver after allogeneic bone marrow transplantation.
    Tanaka J; Imamura M; Kasai M; Masauzi N; Watanabe M; Matsuura A; Morii K; Kiyama Y; Naohara T; Higa T
    Transplantation; 1993 Feb; 55(2):430-2. PubMed ID: 8434396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.